Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001001415 | SCV001158650 | pathogenic | not specified | 2018-08-21 | criteria provided, single submitter | clinical testing | The F9 c.719G>A; p.Trp240Ter variant, also known as Trp194Ter, is published in individuals and families with severe hemophilia (Green 1989, F9 database and references therein). The variant is listed in the ClinVar database (Variation ID: 10583), but is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Considering available information, this variant is classified as pathogenic. References: Link to F9 database: http://www.factorix.org Green PM et al. Molecular pathology of haemophilia B. EMBO J. 1989 Apr;8(4):1067-72. |
OMIM | RCV002282420 | SCV000031560 | pathogenic | Hereditary factor IX deficiency disease | 1989-04-01 | no assertion criteria provided | literature only |